Total Payments
$897.29
2024 Payments
$50.01
Companies
14
Transactions
30
Medicare Patients
5,478
Medicare Billing
$2.8M
Payment Breakdown by Category
Food & Beverage$897.29 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $897.29 | 30 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BARD PERIPHERAL VASCULAR, INC. | $374.81 | 8 | $0 (2019) |
| Boston Scientific Corporation | $84.64 | 1 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $65.78 | 2 | $0 (2024) |
| Amgen Inc. | $53.48 | 2 | $0 (2019) |
| Astellas Pharma US Inc | $45.28 | 2 | $0 (2017) |
| Genentech USA, Inc. | $44.32 | 3 | $0 (2018) |
| Horizon Pharma plc | $41.31 | 2 | $0 (2018) |
| Otsuka America Pharmaceutical, Inc. | $37.35 | 2 | $0 (2020) |
| Medtronic, Inc. | $35.65 | 2 | $0 (2023) |
| CardioFocus, Inc. | $31.84 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $50.01 | 2 | Novartis Pharmaceuticals Corporation ($33.60) |
| 2023 | $67.83 | 3 | Medtronic, Inc. ($35.65) |
| 2022 | $51.70 | 2 | CardioFocus, Inc. ($31.84) |
| 2020 | $104.64 | 2 | Boston Scientific Corporation ($84.64) |
| 2019 | $51.24 | 2 | Amgen Inc. ($28.23) |
| 2018 | $193.77 | 9 | Bard Peripheral Vascular, Inc. ($80.41) |
| 2017 | $378.10 | 10 | Bard Peripheral Vascular, Inc. ($271.39) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/20/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $33.60 | General |
| 05/14/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Diabetes | ||||||
| 11/28/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $32.18 | General |
| 07/18/2023 | Medtronic, Inc. | ELLIPSYS VASCULAR ACCESS SYSTEM (Device) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Catheters | ||||||
| 07/13/2023 | Medtronic, Inc. | ELLIPSYS VASCULAR ACCESS SYSTEM (Device) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Catheters | ||||||
| 04/19/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Iron Deficiency Anemia | ||||||
| 04/13/2022 | CardioFocus, Inc. | HEARTLIGHT SYSTEM (Device) | Food and Beverage | In-kind items and services | $31.84 | General |
| Category: ATRIAL FIBRILATION | ||||||
| 03/06/2020 | Boston Scientific Corporation | GENERAL - ANGIOPLASTY (Device) | Food and Beverage | In-kind items and services | $84.64 | General |
| Category: ANGIOPLASTY | ||||||
| 03/06/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: NEPHROLOGY | ||||||
| 05/28/2019 | Amgen Inc. | Parsabiv (Biological) | Food and Beverage | In-kind items and services | $28.23 | General |
| Category: Nephrology | ||||||
| 05/08/2019 | BARD PERIPHERAL VASCULAR, INC. | VENOVO (Device) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: PERIPHERAL VASCULAR | ||||||
| 10/23/2018 | Amgen Inc. | Parsabiv (Biological) | Food and Beverage | In-kind items and services | $25.25 | General |
| Category: Nephrology | ||||||
| 09/04/2018 | Horizon Pharma plc | KRYSTEXXA (Drug) | Food and Beverage | In-kind items and services | $26.21 | General |
| Category: KRYSTEXXA | ||||||
| 08/30/2018 | Bard Peripheral Vascular, Inc. | FLUENCY (Device) | Food and Beverage | In-kind items and services | $41.56 | General |
| Category: VASCULAR | ||||||
| 08/02/2018 | Bard Peripheral Vascular, Inc. | FLAIR (Device) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: VASCULAR | ||||||
| 05/29/2018 | Genentech USA, Inc. | Rituxan (Biological) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: BioOncology/Immunology | ||||||
| 05/04/2018 | Bard Peripheral Vascular, Inc. | FLAIR (Device) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: VASCULAR | ||||||
| 02/27/2018 | Genentech USA, Inc. | Rituxan (Biological) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: BioOncology/Immunology | ||||||
| 02/22/2018 | Horizon Pharma plc | RAYOS (Drug), RAYOS, RAYOS | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: RAYOS | ||||||
| 01/08/2018 | OPKO Pharmaceuticals, LLC | Rayaldee (old) (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Hyperparathyroidism | ||||||
| 11/17/2017 | Bard Peripheral Vascular, Inc. | BPV-Fluency (Device) | Food and Beverage | Cash or cash equivalent | $79.73 | General |
| Category: Vascular | ||||||
| 11/16/2017 | Bard Peripheral Vascular, Inc. | BPV-Lutonix (Device) | Food and Beverage | Cash or cash equivalent | $151.45 | General |
| Category: Vascular | ||||||
| 10/30/2017 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Hyperparathyroidism | ||||||
| 08/10/2017 | Bard Peripheral Vascular, Inc. | BPV-Fluency (Device) | Food and Beverage | Cash or cash equivalent | $18.48 | General |
| Category: Vascular | ||||||
| 07/21/2017 | Astellas Pharma US Inc | Prograf (Drug), Astagraf, Cresemba | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,031 | 11,858 | $1.9M | $470,313 |
| 2022 | 16 | 1,179 | 13,392 | $2.4M | $593,280 |
| 2021 | 19 | 1,300 | 9,639 | $3.0M | $743,183 |
| 2020 | 20 | 1,968 | 8,905 | $4.1M | $1.0M |
Total Patients
5,478
Total Services
43,794
Medicare Billing
$2.8M
Procedure Codes
72
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 36902 | Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | Office | 2023 | 126 | 162 | $610,470 | $160,313 | 26.3% |
| 36905 | Removal and/or dissolving of blood clot in hemodialysis circuit and balloon dilation of dialysis segment with imaging review by radiologist, with balloon tube | Office | 2023 | 32 | 53 | $377,157 | $100,267 | 26.6% |
| 36581 | Replacement of tunneled central venous tube | Office | 2023 | 60 | 91 | $221,636 | $56,646 | 25.6% |
| 36215 | Insertion of tube into chest or arm artery, each first order branch | Office | 2023 | 46 | 71 | $228,917 | $31,897 | 13.9% |
| 36901 | Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | Office | 2023 | 51 | 55 | $121,106 | $30,962 | 25.6% |
| 36907 | Balloon dilation of dialysis segment with review by radiologist | Office | 2023 | 33 | 46 | $84,823 | $22,670 | 26.7% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2023 | 228 | 355 | $55,380 | $14,705 | 26.6% |
| 36558 | Insertion of tunneled central venous tube for infusion (5 years or older) | Office | 2023 | 18 | 18 | $46,888 | $11,749 | 25.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 81 | 171 | $27,360 | $10,399 | 38.0% |
| 75710 | Review by radiologist of arm or leg artery image | Office | 2023 | 47 | 72 | $33,765 | $8,830 | 26.2% |
| 77001 | Fluoroscopic guidance for insertion or removal of central vein access device | Office | 2023 | 73 | 107 | $33,521 | $8,475 | 25.3% |
| 36589 | Removal of tunneled central venous tube | Office | 2023 | 38 | 38 | $19,596 | $4,800 | 24.5% |
| 37799 | Other procedure on blood vessel | Office | 2023 | 12 | 17 | $15,300 | $3,293 | 21.5% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2023 | 13 | 29 | $4,930 | $2,021 | 41.0% |
| 99153 | Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | Office | 2023 | 65 | 160 | $5,439 | $1,471 | 27.0% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 90 | 10,395 | $24,948 | $1,225 | 4.9% |
| 76937 | Ultrasonic guidance for blood vessel access | Office | 2023 | 18 | 18 | $2,212 | $590.40 | 26.7% |
| 36902 | Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | Office | 2022 | 133 | 183 | $710,023 | $189,075 | 26.6% |
| 36905 | Removal and/or dissolving of blood clot in hemodialysis circuit and balloon dilation of dialysis segment with imaging review by radiologist, with balloon tube | Office | 2022 | 57 | 78 | $572,511 | $154,685 | 27.0% |
| 36581 | Replacement of tunneled central venous tube | Office | 2022 | 57 | 86 | $216,347 | $56,755 | 26.2% |
| 36215 | Insertion of tube into chest or arm artery, each first order branch | Office | 2022 | 66 | 91 | $301,152 | $42,168 | 14.0% |
| 36901 | Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | Office | 2022 | 57 | 65 | $146,380 | $38,286 | 26.2% |
| 36907 | Balloon dilation of dialysis segment with review by radiologist | Office | 2022 | 49 | 70 | $132,397 | $35,870 | 27.1% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2022 | 260 | 403 | $62,910 | $17,070 | 27.1% |
| 36558 | Insertion of tunneled central venous tube for infusion (5 years or older) | Office | 2022 | 16 | 18 | $48,078 | $12,860 | 26.7% |
About Dr. Edward Rhee, MD
Dr. Edward Rhee, MD is a Nephrology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/11/2005. The National Provider Identifier (NPI) number assigned to this provider is 1649272576.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edward Rhee, MD has received a total of $897.29 in payments from pharmaceutical and medical device companies, with $50.01 received in 2024. These payments were reported across 30 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($897.29).
As a Medicare-enrolled provider, Rhee has provided services to 5,478 Medicare beneficiaries, totaling 43,794 services with total Medicare billing of $2.8M. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Houston, TX
- Active Since 08/11/2005
- Last Updated 04/09/2025
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1649272576
Products in Payments
- BPV-Lutonix (Device) $151.45
- BPV-Fluency (Device) $119.94
- GENERAL - ANGIOPLASTY (Device) $84.64
- Parsabiv (Biological) $53.48
- Prograf (Drug) $45.28
- Rituxan (Biological) $44.32
- FLUENCY (Device) $41.56
- FLAIR (Device) $38.85
- ELLIPSYS VASCULAR ACCESS SYSTEM (Device) $35.65
- HEARTLIGHT SYSTEM (Device) $31.84
- KRYSTEXXA (Drug) $26.21
- VENOVO (Device) $23.01
- JYNARQUE (Drug) $20.00
- INJECTAFER (Drug) $19.86
- SAMSCA (Drug) $17.35
- Rayaldee (old) (Drug) $16.52
- JARDIANCE (Drug) $16.41
- Mitigare (Drug) $15.86
- RAYOS (Drug) $15.10
- Rayaldee (Drug) $14.18
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Houston
Sreedhar Mandayam, M.d, M.D
Nephrology — Payments: $789,657
Nephrology $789,657
Dr. Christopher Kwoh, M.d, M.D
Nephrology — Payments: $420,843
Nephrology $420,843
Dr. Maher Bishara, M.d, M.D
Nephrology — Payments: $119,839
Nephrology $119,839
Rajeev Raghavan, Md, MD
Nephrology — Payments: $119,615
Nephrology $119,615
Dr. Horacio Adrogue, Md, MD
Nephrology — Payments: $102,891
Nephrology $102,891
Dr. Jaya Kala, Md, MD
Nephrology — Payments: $81,881
Nephrology $81,881